Osen W - Search Results

1

Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6 mice.

Steinberg T, Ohlschläger P, Sehr P, Osen W, Gissmann L. Steinberg T, et al. Among authors: osen w. Vaccine. 2005 Jan 19;23(9):1149-57. doi: 10.1016/j.vaccine.2004.08.027. Vaccine. 2005. PMID: 15629358

2

Human papillomavirus type 16 (HPV 16) E7 and major histocompatibility complex (MHC) class I and II expression in human keratinocytes in culture.

Hoos A, D'Incan C, Gissmann L, Altmann A, Momburg F, Nindl I, Osen W, Schönning BH, Jochmus I. Hoos A, et al. Among authors: osen w. Arch Virol. 1996;141(3-4):449-58. doi: 10.1007/BF01718309. Arch Virol. 1996. PMID: 8645087

3

Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.

Jochmus I, Osen W, Altmann A, Buck G, Hofmann B, Schneider A, Gissmann L, Rammensee HG. Jochmus I, et al. Among authors: osen w. J Gen Virol. 1997 Jul;78 ( Pt 7):1689-95. doi: 10.1099/0022-1317-78-7-1689. J Gen Virol. 1997. PMID: 9225046

4

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection.

Schäfer K, Müller M, Faath S, Henn A, Osen W, Zentgraf H, Benner A, Gissmann L, Jochmus I. Schäfer K, et al. Among authors: osen w. Int J Cancer. 1999 Jun 11;81(6):881-8. doi: 10.1002/(sici)1097-0215(19990611)81:6<881::aid-ijc8>3.0.co;2-t. Int J Cancer. 1999. PMID: 10362134

5

E7-specific cytotoxic T cell tolerance in HPV-transgenic mice.

Borchers A, Braspenning J, Meijer J, Osen W, Gissmann L, Jochmus I. Borchers A, et al. Among authors: osen w. Arch Virol. 1999;144(8):1539-56. doi: 10.1007/s007050050609. Arch Virol. 1999. PMID: 10486109

6

Immunization against human papillomavirus infection and associated neoplasia.

Osen W, Jochmus I, Müller M, Gissmann L. Osen W, et al. J Clin Virol. 2000 Oct;19(1-2):75-8. doi: 10.1016/s1386-6532(00)00090-1. J Clin Virol. 2000. PMID: 11091150

7

A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity.

Osen W, Peiler T, Ohlschläger P, Caldeira S, Faath S, Michel N, Müller M, Tommasino M, Jochmus I, Gissmann L. Osen W, et al. Vaccine. 2001 Jul 20;19(30):4276-86. doi: 10.1016/s0264-410x(01)00154-2. Vaccine. 2001. PMID: 11457555

8

Therapeutic vaccines for human papillomaviruses.

Gissmann L, Osen W, Müller M, Jochmus I. Gissmann L, et al. Among authors: osen w. Intervirology. 2001;44(2-3):167-75. doi: 10.1159/000050044. Intervirology. 2001. PMID: 11509878 Review.

9

Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination.

Michel N, Osen W, Gissmann L, Schumacher TN, Zentgraf H, Müller M. Michel N, et al. Among authors: osen w. Virology. 2002 Mar 1;294(1):47-59. doi: 10.1006/viro.2001.1321. Virology. 2002. PMID: 11886264 Free article.

10

T cell response to human papillomavirus 16 E7 in mice: comparison of Cr release assay, intracellular IFN-gamma production, ELISPOT and tetramer staining.

Michel N, Ohlschläger P, Osen W, Freyschmidt EJ, Guthöhrlein H, Kaufmann AM, Müller M, Gissmann L. Michel N, et al. Among authors: osen w. Intervirology. 2002;45(4-6):290-9. doi: 10.1159/000067923. Intervirology. 2002. PMID: 12566712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters